Skip to main content

Therapeutics Startups

Updated July 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,708 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,708
Total Funding
$1.2B
Avg Funding
$47.0M
Global Reach
5
countries

Top Cities for Therapeutics

Philadelphia
Woburn
Roma
Farmington
Flagstaff
Menlo Park

Recently Funded Companies

Export
Philadelphia, United States

PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.

Apr 2022

Founder Contacts

30,000+ verified contacts

Woburn, United States

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

$54.0M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Roma, Italy

Medicud develops a device for treating wounds with negative pressure dressing.

$647K raised
Apr 2025

Founder Contacts

30,000+ verified contacts

Farmington, United States

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

$6.6M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Flagstaff, United States

Cordant Health Solutions offers tools for monitoring health, chronic pain, and criminal justice cases.

$6.0M raised
Apr 2023

Founder Contacts

30,000+ verified contacts

Menlo Park, United States

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

$10.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

$85.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Belfast, United Kingdom

SignaCor is a clinical-stage biotech company exploring therapeutics for cardiac disorders, specifically hypertrophic cardiomyopathy.

$332K raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.

$86.5M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Cambridge, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

$88.0M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Boston, United States

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

$7.0M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Del Mar, United States

CeleCor Therapeutics develops first-point contact treatments for segment elevated myocardial infarction.

$45.5M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Jersey City, United States

Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.

$5.6M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

Edinburgh, United Kingdom

Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.

$10.9M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

San Diego, United States

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

$6.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Vancouver, Canada

Defence Therapeutics is a scientific pioneer on a journey to uncover enhanced treatment solutions for future generations.

$7.1M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Hong Kong, Hong Kong

Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.

$3.5M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

Natick, United States

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

$182.0M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

$40.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Boston, United States

NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.

$19.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Swarm Oncology is a biotechnology company that develops novel T cell therapies for cancer patients.

$8.1M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Cognito Therapeutics develops neurotechnology therapies to treat neurodegenerative diseases by stimulating specific brain activity patterns.

$105.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

$366.9M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Westport, United States

Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.

$22.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Oxford, United Kingdom

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

$9.3M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Showing 701 to 725 of 1,708 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,708 therapeutics companies tracked in the VCBacked database.

Average Funding
$47.0M
Total Funding Tracked
$1.2B
Countries Represented
5

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Cambridge
6 companies$771.4M
2.Boston
2 companies$26.0M
3.Philadelphia
1 companiesUndisclosed
4.Woburn
1 companies$54.0M
5.Roma
1 companies$647K

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,708 Therapeutics Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 29 | VCBacked